Marathon Trading Investment Management LLC C4 Therapeutics, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	SELL	$4.05 - $8.1 $200,880 - $401,760	-49,600 Reduced 77.5%	14,400 $66,000
Q1 2024 May 10, 2024	BUY	$5.3 - $11.0 $339,200 - $704,000	64,000 New	64,000 $522,000

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

Lynx1 Capital Management LP San Juan, PR

6.88M
Shares

$30.1 Million
14.04% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

6.6M
Shares

$28.9 Million
3.2% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

5.68M
Shares

$24.9 Million
0.16% of portfolio
Ra Capital Management, L.P. Boston, MA

4.88M
Shares

$21.4 Million
0.39% of portfolio
Black Rock Inc. New York, NY

4.55M
Shares

$19.9 Million
0.0% of portfolio

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $214M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account